Foremost Companies in the Lipid Nanoparticles Market: Avanti Polar Lipids (Croda International plc) (US) and Merck KGaA (Germany)
The global lipid nanoparticles market is projected to reach USD 350.5 million by 2029 from USD 271.8 million in 2024, at a CAGR of 5.2% during the forecast period of 2024 to 2029. The global lipid nanoparticles services market is projected to reach USD 238.1 million by 2029 from USD 135.5 million in 2024, at a CAGR of 11.9% during the forecast period of 2024 to 2029.
Growth in the lipid nanoparticles market can be attributed to factors such as increasing use of lipid nanoparticles in ant-cancer therapies, increasing use of lipid-nanoparticles in RNA-based therapies. On the other hand, stringent regulation associated with lipid nanoparticles are expected to hinder market growth.
The global lipid nanoparticles market is consolidated, with Avanti Polar Lipids (Croda International plc) (US), Merck KGaA (Germany), NOF CORPORATION (Japan), and Nippon Fine Chemical (Japan), accounting for the 70-75% of the market share globally.
To know about the assumptions considered for the study download the pdf brochure
Avanti Polar Lipids (Croda International plc) (US) founded in 1967 in Alabaster, Alabama, produces high-purity lipids for use in biochemistry, molecular biology, and pharmaceutical research. Croda International subsidiary Avanti markets phospholipids, sphingolipids, sterols and custom synthesis. The company offers extensive portfolio of lipid nanoparticles, which allows them to cater to various customer applications. Avanti also provides custom lipid synthesis services, enabling them to meet specific requirements of customers. Avanti invests heavily in research and development and also collaborates with academic and research institutes to develop new lipid formulations and technologies.
Merck KGaA (Germany) is a healthcare & life sciences company that involved in development, manufacturing, and marketing of pharmaceutical and biopharmaceutical products, specialty chemicals, high-tech materials, and life science research and diagnostic tools. The company sells a variety of lipid nanoparticles items covering several research, bioprocessing, reagents, kits, assays, software, catering to diverse research, and uses in clinical medicine. Merck has a diverse network and has developed ties with pharmaceutical, biotech, and research labs, businesses all across the globe. Merck has focussed on building its CDMO capabilities in the RNA production space to offer end-to-end solutions. For example, a biotech contract develops and Merck has agreed to purchase production company Exelead for about USD780.0 million dollars in cash.
NOF CORPORATION (Japan) is a well-known chemical manufacturer that makes a large range of produce. Furthermore, the company expanded by collaborating with key players. For instance,in April 2024, NOF CORPORATION collaborated with Phosphorex to supply lipid nanoparticle formulations by utilizing NOF's proprietary ionizable lipid, which is known as the COATSOME® SA Series. These lipids complex nucleic acids, such as mRNA, siRNA, and pDNA, into cells efficiently with controlled targeting to organs—the liver, spleen, and lymph nodes—with low toxicity. NOF's COATSOME® SS Series strengthens its position in lipid nanoparticles-based drug delivery solutions. In addition, NOF synthesizes high-purity lipid derivatives supporting lipid nanoparticles formulation of nucleic acid and gene therapy drugs, as well as liposome and emulsion formulations of small molecule drugs. Phosphorex will serve as a drug delivery-focused CDMO partner with NOF to provide one-stop services in lipid nanoparticles materials development, formulation, and scale-up manufacturing.
Related Reports:
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
